[Developmental aspects of the Rubino reaction]

Area of Science:

• Immunology
• Infectious Diseases
• Dermatology

Context:

• Leprosy, a chronic infectious disease, presents diverse clinical forms.
• Accurate assessment of disease activity is crucial for treatment decisions.
• The Rubino reaction's utility in leprosy management requires further investigation.

Purpose:

• To evaluate the correlation between the Rubino reaction and clinical parameters in leprosy patients.
• To assess the Rubino reaction's positivity in relation to the clinical form, E.N.L. (erythema nodosum leprosum), and disease activity.
• To determine if the Rubino reaction can serve as a marker for clinical cure in lepromatous leprosy.

Summary:

• The Rubino reaction was assessed in 178 leprosy patients classified by the 1953 Madrid Congress criteria.
• Tuberculoid leprosy patients consistently showed negative Rubino reactions.
• Borderline leprosy patients had a 9% positive Rubino reaction, unrelated to other parameters.
• Lepromatous leprosy patients exhibited a significant difference in Rubino reaction positivity based on disease activity (55% positive in active vs. 6% in inactive).

Impact:

• The Rubino reaction's negativity in clinically cured patients suggests its potential role in guiding medication discontinuation.
• This test could aid in identifying lepromatous leprosy patients at low risk of relapse.
• Incorporating the Rubino reaction into clinical cure criteria may optimize leprosy treatment protocols.